03/04/2019 16:19:21

CLASS ACTION UPDATE for AVEO, TAP, AVP and INGN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, April 03, 2019 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links provided. There is no cost or obligation to you.

AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO)

Class Period: August 4, 2016 - January 31, 2019

Lead Plaintiff Deadline: April 26, 2019

Join the action: https://www.zlk.com/pslra-1/aveo-pharmaceuticals-inc-loss-form?wire=3

The lawsuit alleges: AVEO Pharmaceuticals, Inc. made materially false and/or misleading statements throughout the class period and/or failed to disclose that: (i) the TIVO‑3 trial was inadequately designed to address the OS concerns regarding AVEO’s lead candidate drug, tivozanib, from the TIVO-1 trial presented in June 2013; (ii) tivozanib had insufficient survival data to meet FDA approval following its initial 2013 rejection; (iii) this lack of sufficient survival data would put tivozanib at greater risk of delayed FDA approval; and (iv) as a result, AVEO’s public statements were materially false and misleading at all relevant times.

To learn more about the AVEO Pharmaceuticals, Inc. class action contact jlevi@levikorsinsky.com.

Molson Coors Brewing Company (NYSE: TAP)

Class Period: February 14, 2017 - February 12, 2019

Lead Plaintiff Deadline: April 16, 2019

Join the action: https://www.zlk.com/pslra-1/molson-coors-brewing-company-loss-form?wire=3

The lawsuit alleges that, during the class period, Molson Coors Brewing Company made materially false and/or misleading statements and/or failed to disclose that: (1) Molson Coors failed to properly reconcile the outside basis deferred income tax liability for Molson Coors’ investment in its MillerCoors, LLC partnership; (2) consequently, Molson Coors misreported net income in its consolidated financial statements for the fiscal years ending December 31, 2016 and December 31, 2017, resulting in an overall downward revision to net income; (3) Molson Coors lacked adequate internal controls over financial reporting; and (4) as a result, defendants’ statements about Molson Coors’ business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

To learn more about the Molson Coors Brewing Company class action contact jlevi@levikorsinsky.com.

Avon Products, Inc. (NYSE: AVP)

Class Period: August 2, 2016 - August 2, 2017

Lead Plaintiff Deadline: April 15, 2019

Join the action: https://www.zlk.com/pslra-1/avon-products-inc-loss-form?wire=3

In order to inflate its reported revenue and representative growth metric during the Class Period, Avon engaged in an undisclosed scheme whereby it significantly loosened its credit terms in order to recruit new representatives in Brazil, its largest market. Avon did not disclose the changes to its credit terms in Brazil. Avon also failed to increase its allowance for doubtful accounts to account for the changes to its credit terms in Brazil.

To learn more about the Avon Products, Inc. class action contact jlevi@levikorsinsky.com.

Inogen, Inc. (NASDAQGS: INGN)

Class Period: November 8, 2017 - February 26, 2019

Lead Plaintiff Deadline: May 6, 2019

Join the action: https://www.zlk.com/pslra-1/inogen-inc-loss-form?wire=3

The lawsuit alleges: Inogen, Inc. made materially false and/or misleading statements throughout the class period and/or failed to disclose that: (i) Inogen had overstated the true size of the total addressable market (“TAM”) for its portable oxygen concentrators and had misstated the basis for its calculation of the TAM; (ii) Inogen had falsely attributed its sales growth to the strong sales acumen of its salesforce, when in reality it was due in large part to sales tactics designed to deceive its elderly customer base; (iii) the growth in Inogen’s domestic business-to-business sales to home medical equipment (“HME”) providers was inflated, unsustainable and was eroding direct-to-consumer sales; and (iv) very little of Inogen’s business was actually coming from the more stable Medicare market.

To learn more about the Inogen, Inc. class action contact jlevi@levikorsinsky.com.

You have until the lead plaintiff deadlines to request the court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Toll Free: (877) 363-5972

Fax: (212) 363-7171

www.zlk.com 

250x148_zlk.jpg

Related content
15 Aug - 
Shareholder Investigation Alert: Halper Sadeh LLP is In..
15 Aug - 
Bragar Eagel & Squire is Investigating Certain Officers..
13 Aug - 
Molson Investigated by Merchant Law Group LLP For Viola..
Del

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

Regulatory news

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Start of Day Message
2
Director Declaration
3
Industry Welcomes Second-Generation Low Emission Methanol-Fuelled Vessels
4
What the Media Missed at Trump's Meeting with Romania's President Today
5
True Nature Holding Announces A Private Offering Under Rule 506(C) Of Its New Series A, 10% Cumulative Redeemable Perpetual Preferred Stock Offering

Related stock quotes

Avon Products Inc 4.080 -2.4% Stock price decreasing
Aveo Pharmaceuticals Inc 0.6779 0.4% Stock price increasing
Inogen Inc 41.82 -1.6% Stock price decreasing
Molson Coors Brewing Com.. 52.16 -0.6% Stock price decreasing

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
21 August 2019 04:44:12
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190819.1 - EUROWEB5 - 2019-08-21 05:44:12 - 2019-08-21 04:44:12 - 1000 - Website: OKAY